Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors
Clinical trial NCT00207077 · COMPLETED
Trial details
- NCT number
- NCT00207077
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-05-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.